Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034916.xml
Download PDF
Nervenheilkunde 2008; 27(12): 1097-1101
DOI: 10.1055/s-0038-1627349
DOI: 10.1055/s-0038-1627349
Originaler Artikel
Alternative Therapien bei Kopfschmerzen
Was ist gesichert?Alternative medicine in patients with headacheFurther Information
Publication History
Eingegangen am:
03 September 2008
angenommen am:
08 September 2008
Publication Date:
20 January 2018 (online)
Zusammenfassung
Die Anzahl von alternativen Therapieangeboten ist bei chronischen Kopfschmerzen, ähnlich wie bei anderen chronischen Erkrankungen, nicht überschaubar. Im Gegensatz aber zu vielen anderen Bereichen der Medizin gibt es für das Gebiet der Kopfschmerzbehandlung erste wissenschaftliche Studien, die sich mit dem Wert dieser Verfahren im Vergleich zu Standardverfahren befassen. Dieses gilt insbesondere für pflanzliche Wirkstoffe (z. B. Pestwurz) oder die Akupunktur. Im Folgenden wird gegliedert nach Phytotherapie, Nahrungsergänzungsstoffen, physikalischen Verfahren (Akupunktur), operativen Verfahren, psychologischen Verfahren und zuletzt magnetischer/elektrischer Stimulation, ein Überblick über den Stand der wissenschaftlichen Diskussion gegeben.
Summary
The number of therapy options for chronic headaches are uncountable, similarly to other chronic diseases. In contrast to other areas of medical science, in the area of headache therapy there are first scientific studies about the efficiency of so-called alternative treatment options in comparison to classic therapy. Studies are especially available for phytotherapy, food supplements, physical therapy, acupuncture, surgical procedures, and stimulation with electrical or magnetic fields. The following article gives a summary of the current discussion.
-
Literatur
- 1 Gendolla A, Pageler L, Diener HC. Migräne – Kosten und Erfolg nicht medikamentöser Therapieverfahren und Häufigkeit diagnostischer Maßnahmen. Schmerz 1999; 13: 196-200.
- 2 Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J Intern Med 2003; 253 (Suppl. 02) 181-188.
- 3 Göbel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 1994; 14 (Suppl. 03) 228-234.
- 4 Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004; 63 (Suppl. 12) 2240-2244.
- 5 Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000; 38 (Suppl. 09) 430-435.
- 6 Diener HC, Rahlfs VW, Danesch U. The first placebo- controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurl 2004; 51 (Suppl. 02) 89-97.
- 7 Oelkers-Ax R, Leins A, Parzer P, Hillecke T, Bolay HV, Fischer J, Bender S, Hermanns U, Resch F. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain 2008; 12 (Suppl. 03) 301-313.
- 8 Agosti R, Duke RK, Chrubasik JE, Chrubasik S. Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine 2006; 13 9–10 743-746.
- 9 Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, doubleblind, multicentre, placebo-controlled study. Cephalalgia 2005; 25 (Suppl. 11) 1031-1041.
- 10 Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis – a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002; 22 (Suppl. 07) 523-532.
- 11 Evans RW, Taylor FR. „Natural“ or alternative medications for migraine prevention. Headache 2006; 46 (Suppl. 06) 1012-1018.
- 12 Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50 (Suppl. 02) 466-470.
- 13 Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994; 14 (Suppl. 05) 328-329.
- 14 Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhäupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004; 11 (Suppl. 07) 475-477.
- 15 Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 2004; 44 (Suppl. 09) 885-890.
- 16 Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005; 64 (Suppl. 04) 713-715.
- 17 Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16 (Suppl. 04) 257-263.
- 18 Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M. Magnesium in the prophylaxis of migraine-- a double-blind placebo-controlled study. Cephalalgia 1996; 16 (Suppl. 06) 436-440.
- 19 Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebocontrolled trial. Headache 2003; 43 (Suppl. 06) 601-610.
- 20 Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, Biason P. Failure of omega-3 polyunsaturated fatty acids in preven- tion of migraine: a double-blind study versus placebo. Cephalalgia 2001; 21 (Suppl. 08) 818-822.
- 21 Alecrim-Andrade J, Maciel-Júnior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia 2006; 26 (Suppl. 05) 520-529.
- 22 Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R. GERAC Migraine Study Group.. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006; 5 (Suppl. 04) 310-316.
- 23 Linde K, Streng A, Jürgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005; 293 (Suppl. 17) 2118-2125.
- 24 Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev Neurother 2007; 7 (Suppl. 09) 1121-34.
- 25 Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, Zenz M, Vickers AJ, Tegenthoff M. Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer- blinded, randomised trial. J Headache Pain 2007; 8 (Suppl. 05) 306-314.
- 26 Melchart D, Streng A, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes M, Hummelsberger J, Irnich D, Weidenhammer W, Willich SN, Linde K. Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 2005; 331 7513 376-382.
- 27 Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 2007; 128 (Suppl. 03) 264-271.
- 28 Biondi DM. Physical treatments for headache: a structured review. Headache 2005; 45 (Suppl. 06) 738-746.
- 29 van Ettekoven H, Lucas C. Efficacy of physiotherapy including a craniocervical training programme for tension-type headache; a randomized clinical trial. Cephalalgia 2006; 26 (Suppl. 08) 983-991.
- 30 Torelli P, Jensen R, Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia 2004; 24 (Suppl. 01) 29-36.
- 31 Evers S, Olesen J. Botulinum toxin in headache treatment: the end of the road?. Cephalalgia 2006; 26 (Suppl. 07) 769-771.
- 32 Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg 2000; 106 (Suppl. 02) 429-434.
- 33 Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg 2004; 114 (Suppl. 03) 652-657.
- 34 Diener HC, Weimar C, Katsarava Z. Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005; 18 (Suppl. 03) 299-304.
- 35 Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv 2007; 69 (Suppl. 05) 740-746.
- 36 Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117 (Suppl. 11) 1397-1404.
- 37 Diener HC. Council of the European Headache Federation. Patent foramen ovale and migraine: no reason to intervene. J Headache Pain 2007; 8 (Suppl. 01) 3-6.
- 38 Kanji N, White AR, Ernst E. Autogenic training for tension type headaches: a systematic review of controlled trials. Complement Ther Med 2006; 14 (Suppl. 02) 144-150.
- 39 Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001; 285 (Suppl. 17) 2208-2215.
- 40 Martin PR, Forsyth MR, Reece J. Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther 2007; 38 (Suppl. 04) 350-363.
- 41 Trautmann E, Lackschewitz H, Kröner-Herwig B. Psychological treatment of recurrent headache in children and adolescents--a meta-analysis. Cephalalgia 2006; 26 (Suppl. 12) 1411-1426.
- 42 Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 2007; 28 (Suppl. 02) S70-7.
- 43 Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: a meta-analysis. Pain 2007; 128 1–2 111-127.
- 44 Al-Khlaiwi T, Meo SA. Association of mobile phone radiation with fatigue, headache, dizziness, tension and sleep disturbance in Saudi population. Saudi Med J 2004; 25 (Suppl. 06) 732-736.
- 45 Seitz H, Stinner D, Eikmann T, Herr C, Röösli M. Electromagnetic hypersensitivity (EHS) and subjective health complaints associated with electromagnetic fields of mobile phone communication-- a literature review published between 2000 and 2004. Sci Total Environ 2005; 349 1–3 45-55.
- 46 Brighina F, Piazza A, Vitello G, Aloisio A, Palermo A, Daniele O, Fierro B. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci 2004; 227 (Suppl. 01) 67-71.
- 47 Chadaide Z, Arlt S, Antal A, Nitsche MA, Lang N, Paulus W. Transcranial direct current stimulation reveals inhibitory deficiency in migraine. Cephalalgia 2007; 27 (Suppl. 07) 833-839.
- 48 Antal A, Brepohl N, Poreisz C, Boros K, Csifcsak G, Paulus W. Transcranial direct current stimulation over somatosensory cortex decreases experimentally induced acute pain perception. Clin J Pain 2008; 24 (Suppl. 01) 56-63.
- 49 Vincent W, Andrasik F, Sherman R. Headache treatment with pulsing electromagnetic fields: a literature review. Appl Psychophysiol Biofeedback 2007; 32 3–4 191-207.
- 50 Goadsby PJ, Bartsch T, Dodick DW. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache 2008; 48 (Suppl. 02) 313-318.